Douglas G. McNeel

Affiliations: 
Cancer Biology University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Molecular Biology, Immunology
Google:
"Douglas McNeel"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McNeel DG, Eickhoff JC, Wargowski E, et al. (2018) Concurrent, but not sequential, PD-1 blockade with a DNA vaccine elicits anti-tumor responses in patients with metastatic, castration-resistant prostate cancer. Oncotarget. 9: 25586-25596
Wargowski E, Johnson LE, Eickhoff JC, et al. (2018) Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine. Journal For Immunotherapy of Cancer. 6: 21
Olson BM, Gamat M, Seliski J, et al. (2017) Prostate cancer cells express more androgen receptor (AR) following androgen deprivation, improving recognition by AR-specific T cells. Cancer Immunology Research
England CG, Jiang D, Ehlerding EB, et al. (2017) (89)Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer. European Journal of Nuclear Medicine and Molecular Imaging
Johnson LE, Olson BM, McNeel DG. (2017) Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination. Journal For Immunotherapy of Cancer. 5: 56
Johnson LE, Olson BM, McNeel DG. (2017) Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination. Journal For Immunotherapy of Cancer. 5: 56
Olson BM, Bradley ES, Sawicki T, et al. (2017) Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD). The Prostate
Heninger E, Krueger TE, Thiede SM, et al. (2016) Inducible expression of cancer-testis antigens in human prostate cancer. Oncotarget
Rekoske BT, McNeel DG. (2016) Immunotherapy for prostate cancer: False promises or true hope? Cancer
England CG, Ehlerding EB, Hernandez R, et al. (2016) Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-labeled Pembrolizumab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
See more...